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ANTIGEN  PRESENTATION  IN  THE 
MURINE  T-LYMPHOCYTE  PROLIFERATIVE  RESPONSE 
I.  Requirement for Genetic Identity at the Major Histocompatibility 
Complex 
BY AKIHIKO YANO, RONALD  H. SCHWARTZ, ANn WILLIAM E. PAUL 
(From the Laboratory  of Immunology, National Institute of Allergy and Infectious  Diseases, 
National Institutes of Health, Bethesda,  Maryland 20014) 
The importance of the macrophage in the initiation of the immune response to 
soluble protein antigens has been demonstrated by several investigators (1-5). 
One of the clearest examples of this is in the guinea pig where the activation of 
proliferative responses by antigen-primed, thymus-dependent (T) lymphocytes 
has been shown to  depend upon the presence of an  auxilliary cell with the 
characteristics of a macrophage (1, 2). In this system, the critical function of the 
live macrophages appears to be the presentation of antigen. One of the striking 
features of this  presentation is  that  it  is  only efficient when the  antigen- 
presenting cell and the responding cell possess a  common allelic form of the 
guinea pig equivalent of/subregions of the major histocompatibility complex 
(MHC) 1 (1, 2). A similar/-region histocompatibility restriction in the activation 
of T lymphocytes in the mouse has been suggested by studies of the transfer of 
delayed hypersensitivity (3) and of  the priming of helper T lymphocytes (4, 5). In 
this communication, we directly demonstrate that the activation of proliferative 
responses of primed mouse peritoneal exudate T lymphocytes by antigen-pulsed 
spleen cells is histocompatibility restricted. Efficient activation of T  lympho- 
cytes from donors primed to 2,4-dinitrophenyl-ovalbumin (DNP-OVA)  occurs 
only when the interacting cells possess a common allelic form of the MHC.  In 
particular, identity at the I-A subregion of the MHC, in the face of differences  in 
all other MHC regions, is sufficient for such activation. 
Materials and Methods 
Animals.  Strains C57BL/10 Sn (B10), B10.A/SgSn (B10.A), B10.D2/nSn  (B10.D2), B10.A(SR)/ 
SgSn,  B10.BR/SgSn,  C57BL/6J  (B6), A/HeJ (A),  (B6  x  A)FI/J hybrids  (B6A  F1), SJL/J,  and 
DBA/2J were obtained from The Jackson Laboratory, Bar Harbor, Maine. A.TL/Sf  mice were the 
progeny of breeding pairs kindly provided by Dr.  Donald Shreffler and Dr. Chella David, Wash- 
ington University, School of Medicine, St. Louis, Mo. Breeding pairs of the B10.A(4R)/Sg  strain 
were kindly provided by Dr. Jack Stimpfling, McLaughlin Research Institute, Great Falls, Mont. 
BALB/c AnN mice were obtained from the Division of Research Services of the National Institutes 
Abbreviations used in this paper:  DH, delayed-type hypersensitivity; DNP-OVA; 2,4-dinitro- 
phenyl-ovalbumin; FCS, fetal calf serum; MHC,  major histocompatibility complex;  MLR, mixed 
lymphocyte reaction;  PETLES,  peritoneal exudate  T-lymphocyte-enriched cells;  PFC,  plaque- 
forming cell. 
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of Health,  Bethesda,  Md.  The (B10  x  B10.D2)F1  hybrids were bred in the Division of Research 
Services from the parental strains, C57BL/10SnN and B10.D2/nSnN. The (B10 x  B10.A)F1 hybrids 
were bred in our laboratory from the Jackson parental strains B10 and B10.A. Mice of both sexes 
were used between 6 and 18 wk of age. 
Antigens.  DNP derivatives of OVA were prepared by reacting 200 mg of twice recrystallized 
OVA (Mann Research Laboratories, New York) with 10 ~1 of 2,4-dinitrofluorobenzene (Eastman 
Organic Chemicals Div., Eastman Kodak Co., Rochester, N. Y.) in 5 ml of borate buffer, pH 8.0. 
The reaction was carried out in the dark for 24 h with constant stirring at room temperature. The 
supernate was dialyzed against phosphate-buffered saline, pH  7.2 and any precipitated protein 
removed by centrifugation (2,000 rpm ×  10 min). These conjugates contained -6 tool DNP/mol of 
protein and are designated DNPeOVA. 
Immunization.  DNPeOVA was emulsified in complete Freund's adjuvant containing 1 mg/ml 
of killed Mycobacterium tuberculosis  (H37Ra)  organisms  (Difco  Laboratories,  Detroit,  Mich.). 
Animals were  immunized in the hind foot pads  with  10  fig of antigen  in a  total of 0.1  ml of 
emulsion. 
Preparation of  Peritoneal Exudate T-Lymphocyte-Enriched Cells (PETLES).  The original and 
slightly  modified  procedures  for  preparing  PETLES  are  described  in  detail  elsewhere  (6-8). 
Briefly,  2-3  wk  after immunization,  thioglycollate-induced peritoneal exudate  cells were  har- 
vested and passed over nylon wool columns. The PETLES population eluted from nylon columns 
contained an average of 5% macrophages, 40% lymphocytes, 53% eosinophils, and <2% B lympho- 
cytes. 
Preparation of Spleen Cells.  Animals were sacrificed by cervical dislocation and the spleens 
removed aseptically. Spleen cells were flushed out of the capsule using a 21 gauge needle and a  12 
ml syringe filled with KHCO3-buffered NH4C1  (9). The spleen was squeezed gently with a  pair of 
forceps  during the  flushing to  insure  maximum  release  of cells;  the erythrocytes  were  lysed 
during this procedure. The cell suspension was passed through a  wire screen (no. 180 mesh) and 
washed once with Spinner's modified Eagle's minimal essential medium. The remaining nucleated 
cells were resuspended in RPMI-1640 medium supplemented with 10% heat-inactivated fetal calf 
serum (FCS; Grand Island Biological Co., Grand Island, N. Y.), 50 U/ml of penicillin G, 250 ~g/ml 
of gentamicin (Schering Corp., Kenilworth, N. J.), and 2  x  10 -~ M 2-mercaptoethanol. The cells 
were counted and kept on ice until ready for use.  Although other tissues such as  nonimmune 
PETLES and peritoneal exudate cells were used as sources of antigen-presenting cells, spleen cells 
were utilized in most of the experiments described in this paper because they presented DNPeOVA 
well and were the easiest to preparg. 
Procedure of  Brief  Antigen Pulsing.  The spleen cells (10 x  106/ml) were incubated for 60 rain at 
37°C in RPMI-1640 with 10% FCS, containing appropriate concentrations of DNP6OVA and 50/~g/ 
ml of mitomycin-C (Sigma Chemical Co., St. Louis, Mo.). The cells were washed five times at 4°C 
with 1 ml of RPMI-1640 to remove unbound antigen and mitomycin-C, and resuspended in culture 
medium.  These conditions for antigen pulsing were modeled on those previously described  for 
guinea pig peritoneal exudate cells (10,  11). The cells were recounted and adjusted to appropriate 
concentrations for addition to the cell cultures.  In some experiments, DNPeOVA-pulsed or non- 
pulsed spleen cells were killed by incubating at 56°C for 60 min and then cooled to 37°C  before 
mixing with PETLES. 
Cell Cultures.  The  procedure  for  culturing  PETLES  has  been  described  elsewhere  (6,  7). 
Briefly,  100  pl of a  10%  FCS-supplemented modified Eagle's-Hanks' medium  (modified EHAA) 
containing 1-2 x  l0  s PETLES were placed in each well of a  sterile, U bottom polystyrene, micro- 
culture plate  (Cooke  Laboratory Products Div.,  Dynatech Laboratories  Inc.,  Alexandria,  Va.). 
DNPsOVA-pulsed or nonpulsed spleen cell suspensions were added in another 100 ~1 to give a total 
vol of 200 pl. As a control, soluble DNPsOVA was added to some wells to give a total vol of 200 ~1 
and a  final free antigen concentration of 100/~g/ml. The cultures were incubated for 3-6 days at 
37°C in a humidified atmosphere of 3% Cos and 97% air. Approximately 16-18 h before harvesting, 
the cultures were pulsed with 1/~Ci of tritiated-methyl-thymidine (sp act 5 Ci/mmol; Amersham/ 
Searle Corp., Arlington Heights, Ill.). The cells were collected onto glass fiber filter paper strips 
(no. 934 AH, Whatman Inc., Clifton, N. J.) with a Mash II automated harvester (Microbiological 
Associates,  Rockville,  Md.),  and washed with distilled water and 95% ethanol.  The filter disk 
containing each sample was then placed in 2 ml of Hydromix scintillation fluid (Yorktown Re- 
search Inc,, Hackensack, N. J.) and the radioactivity measured in a Beckman liquid scintillation DNPsOVA 
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FIG. i.  Proliferative  response  (cpm -  SEM)  of 1 ×  105 BI0.BR PETLES  to varying 
numbers of syngeneic, mitomycin-C-treated spleen cells,  pulsed (O--O), or not pulsed 
(O--Q) with 30 ~g/ml DNP6OVA. 
counter  (Beckman Instruments  Inc.,  Fullerton,  Calif.).  Determinations were  done  in triplicate 
or duplicate and the data are expressed either as mean counts per minute _+ the standard error of 
the mean or as the difference between antigen-pulsed and antigen-nonpulsed responses. 
Results 
The  Response  of PETLES  to  Antigen  Bound  to  Spleen  Cells.  PETLES 
represent a  unique population of primed T lymphocytes in the mouse which is 
highly enriched  for cells  that  can  proliferate  in  culture  in  response  to  the 
continuous presence  of the priming antigen  (6-8).  In the  experiments to be 
described here, we investigated the parameters of PETLES stimulation when 
antigen was  presented to  the  T  lymphocytes in  a  cell-bound rather than  a 
soluble form. This was achieved by exposing spleen cells from nonimmunized 
donors to antigen for 1 h  at 37°C and then washing away unbound antigen. At 
the same time, the spleen cells were inactivated with mitomycin-C so that only 
the PETLES could incorporate 3H-thymidine. The response of 1  ×  l0  s B10.BR 
PETLES to  DNP6OVA  bound to  varying numbers of B10.BR  spleen cells is 
shown in Fig. 1. The data indicate that a log linear relationship exists between 
the number of DNP6OVA-pulsed spleen cells added and resultant DNA synthe- 
sis  in the  PETLES at a  ratio of spleen cells to  PETLES of 1:1  or less.  The 
maximum proliferative response  was  achieved with  1-2  ×  105  spleen  cells. 
Larger numbers of spleen cells gave no greater response and in fact were often 
suppressive (data not shown). 
The amount of antigen introduced into the system could also be varied by 
altering the concentration of antigen used to pulse the spleen cells. Fig. 2 shows AKIHIKO  YANO~  RONALD  H.  SCHWARTZ,  AND  WILLIAM  E.  PAUL  831 
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FIG.  2.  Responses of 1  x  10  5 B10 PETLES  to  1  x  10  5 syngeneic spleen cells that were 
pulsed with varying concentrations of DNPeOVA.  Results are expressed as cpm +- SEM. 
Each vertical bar represents the upper and lower limits of one SEM. 
the response of PETLES to  1  ×  105 syngeneic B10 spleen cells that  had been 
exposed to various concentrations  of DNP6OVA. Thymidine incorporation into 
new DNA increased as the concentration of antigen increased, up to a dose of 100 
~g/m].  Based on these results,  all subsequent experiments  employed 1  ×  105 
PETLES mixed with i  ×  105 spleen cells pulsed with 30-100 ~g/ml of DNP~OVA. 
The activation of primed PETLES by antigen-pulsed spleen cells, under these 
conditions, appears to reflect an antigen-presentation function of  the spleen cells 
and  is  not  due  to  simple  release  of soluble  antigen  by these  cells.  This  is 
illustrated both by the data presented below that a histocompatibility restriction 
exists in the  capacity of spleen cells to  activate primed  PETLES  and  by the 
finding  that  antigen-pulsed  spleen  cells which  have  been  washed  and  heat- 
treated  before  mixing  with  PETLES  cause  little  or  no  stimulation  in  most 
experiments  (Fig.  3).  In 28 of the 38 experiments shown, stimulation by heat- 
killed spleen cells was  15% or less of the stimulation  achieved with antigen- 
pulsed  live  cells.  There  were  some  experiments,  however,  which  did  show 
significant stimulation by heat-killed cells. In general, the data was disregarded 
from any experiment in which antigen-pulsed,  heat-killed cells stimulated 15% 
or more of the response stimulated by live antigen-pulsed cells, because of the 
likelihood that soluble antigen might be carried over into such cultures. 
Antigen  Presentation  by Syngeneic,  Semisyngeneic,  or Allogeneic  Spleen 
Cells.  Previous studies in the guinea pig (1, 2) have demonstrated the require- 
ment for genetic identity at the  MHC in order for peritoneal exudate cells to 
present antigen  effectively to primed T lymphocytes. Experiments  designed to 
test  whether  similar  genetic  restrictions  applied  to  antigen  presentation  by 
murine  spleen  cells are  shown in Table I.  The  experiments  were set up in a 
crisscross fashion so that each presenting cell population was tested against both 832  GENETICS  OF  T  CELL-MACROPHAGE  INTERACTIONS 
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FIG.  3.  A frequency histogram of 38 experiments in which spleen cells were pulsed with 
10-100 ~g/ml of  DNPsOVA and either added to syngeneic PETLES directly or heated to 56°C 
for 60  min,  cooled to  37°C,  and then added to the PETLES.  The resulting proliferative 
responses are  compared here  by  expressing the  response to  the  heat-killed cells  as  a 
percentage of the response to the live cells. 
syngeneic and allogeneic T lymphocytes. As shown in Table I, when PETLES 
from either B10 or B10.D2 mice primed to DNP6OVA were stimulated in vitro 
with DNP6OVA bound to spleen cells, use of syngeneic cells always resulted in 
greater antigen-specific proliferation (h cpm antigen),  than use of allogeneic 
cells.  Thus,  antigen-pulsed B10  spleen cells presented well to  syngeneic B10 
PETLES (A cpm 30,000) but poorly to allogeneic B10.D2 PETLES (h cpm 1,400) 
while antigen-pulsed B10.D2  spleen cells presented well to syngeneic B10.D2 
PETLES (A cpm 19,600) but poorly to allogeneic B10 PETLES  (h cpm 2,200). 
Semisyngeneic antigen-pulsed (B10  x  B10.D2)F, spleen cells gave intermediate 
levels of stimulation for both types of responding T cells (h cpm of 14,700 for B10 
and 9,000 for B10.D2). 
Stimulation of T-lymphocyte proliferation by antigen-pulsed allogeneic spleen 
cells was a  strong function of the concentration of antigen used to pulse such 
cells.  As shown in Fig.  4,  stimulation of BALB/c PETLES by antigen-pulsed 
syngeneic spleen cells peaked when the spleen cells had been pulsed with 100 AKIHIKO YANO, RONALD H.  SCHWARTZ, AND  WILLIAM E.  PAUL 
TABLE I 
Antigen Presentation by Syngeneic, Semisyngeneic, or AUogeneic Spleen Cells 
833 
Proliferative response on day 4 
PETLES  Spleen cells  DNP6OVA  A cpm  A cpm 
cpm +- SEM  (DNP6-  (MLR)$ 
OVA)* 
BI0§  BI0  Nonpulsed  1,600  -+ 300 
Pulsed  31,600 ± I00  30,000 
(B10 x B10.D2)FI  Nonpulsed  13,600 ± 1,200  12,000 
Pulsed  28,300 ± 1,400  14,700 
B10.D2  Nonpulsed  21,500 ± 100  19,900 
Pulsed  23,700 ± 4,400  2,200 
BI0.D2§  BI0.D2  Nonpulsed  2,600  ± 800 
Pulsed  22,100 ± 2,300  19,600 
(BI0 × BI0.D2)FI  Nonpulsed  29,900 ± 1,000  27,300 
Pulsed  38,900 ± 100  9,000 
B10  Nonpulsed  26,400 ± 2,300  23,800 
Pulsed  27,800 ± 2,100  1,400 
* h cpm (DNPsOVA); cpm obtained with  antigen-pulsed  presenting  cells  minus  cpm  obtained with 
nonpulsed presenting cells. 
$ A cpm (MLR);  cpm  obtained with  nonpulsed  allogeneic  presenting  cells  minus  cpm obtained  with 
nonpulsed syngeneic presenting cells. 
§ 1.5 x 105 DNPeOVA-primed B10 and B10.D2 PETLES were cultured with 1 × 105 DNPeOVA- 
pulsed or  nonpulsed  syngeneic,  semisyngeneic, or  allogeneic  spleen  cells  for  4  days  in  microtiter 
plates. 
/zg/ml, whereas stimulation by antigen-pulsed allogeneic B10 spleen cells was 
still increasing at a  pulsing concentration of 300  /zg/ml. We suspect that the 
stimulation caused by allogeneic spleen cells pulsed with high concentrations of 
DNPsOVA reflects "carryover" of antigen, a phenomenon which would tend to 
obscure the genetic restrictions present in the system. In order to minimize this 
putative antigen carryover and to maximize the genetic differences, most exper- 
iments were carried out using 30-50 ~zg/ml of antigen for pulsing. 
The differences between syngeneic, allogeneic, and semisyngeneic presenting 
cells appeared not to be caused by differences in the time-course of  the prolifera- 
tive responses they stimulated. As shown in Fig. 5, the responses for all three 
types of cells peaked after 4-5 days of in vitro incubation, similar to what has 
been reported for cultures containing free antigen present continuously (6). In 
addition, the hierarchy of presenting activity (syngeneic better than semisynge- 
neic better than allogeneic) was observed at all time points from day 3 to day 6. 
One might explain the genetic restrictions seen in this system by postulating 
a  suppressive  effect in  cultures with  an ongoing mixed lymphocyte reaction 
(MLR). Because only the allogeneic and semiallogeneic cells generate a  MLR 
(Table I), cultures containing them would be the ones that would be suppressed. 
The finding that antigen-presenting F1 cells were superior to allogeneic cells 834  GENETICS  OF  T  CELL-MACROPHAGE  INTERACTIONS 
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FIG.  4.  Response of 1  x  10  5 BALB/c PETLES to  varying concentrations of DNPeOVA- 
pulsed BALB/c  spleen cells  (O--O)  or  DNPeOVA-pulsed B10  spleen cells  (0--0).  The 
results are expressed as h  cpm _+  SEM. 
B10 PETLES  B10.D2 PETLES 
ACPM 
30,000 
20,000 
10,000 
.--// 
SPLEEN 
\T eEL'S 
.L  \  I  B10 
B10.D~ 
3  4  6 
DAYS 
// 
SPLEEN  /  \  CELLS 
.___~  T  ~'~  x B10"D2) F1 
3  4  5  6 
FIG.  5.  Kinetics of antigen presentation by syngeneic (O--O), semisyngeneic (A--A), or 
allogeneic (O--O) spleen cells to 1 x  10  5 B10 PETLES (A) or 1 ×  10  5 B10.D2 PETLES (B). 
The results are expressed as h  cpm +_  SEM. AKIHIKO  YANO,  RONALD  H.  SCHWARTZ,  AND  WILLIAM  E.  PAUL  835 
a. 
Q 
== 
O 
x 
It.. 
o 
z 
Og 
I,U 
40,000 
30,000 
20,000 
B10 (+) +  B10.A(--) 
10,000  ~~,,.~  SlO (--) + BIO.A (+) 
•  ~B10 (--) + B10.A (-) 
I 
B10  3  1A0 
B10.A  3  10 
NUMBER OF SPLEEN CELLS (x 10 4) 
FIG.  6.  Syngeneic cells present antigen better than allogeneic cells in the presence of the 
same MLR. 1 x  105 DNP6OVA-primed B10 PETLES were cultured with mixtures of equal 
numbers of DNP6OVA-pulsed  B10 spleen cells [B10(+)]  and nonpulsed B10.A spleen cells 
[B10.A(-)]  (O--O),  nonpulsed  B10  spleen  cells  [B10(-)]  and  DNP6OVA-pulsed  B10.A 
spleen cells [B10.A(+)]  (O--O), or nonpulsed B10 spleen cells and nonpulsed B10.A spleen 
cells (A--A). Stimulation was assessed 5 days later by measuring the incorporation of  a 16 h 
pulse of tritiated methyl-thymidine. The results are expressed as cpm. 
could be accounted for by a less vigorous suppressive effect because they possess 
only 1/2 the number of MLR-stimulating determinants. Although this last point 
was not always supported by the data, experiments were set up to test directly 
the possibility that a  suppressive effect of an ongoing MLR accounted for the 
genetic restrictions which we observed.  These experiments involved mixing 
equal numbers of syngeneic and allogeneic spleen cells or equal numbers of 
syngeneic and semisyngeneic spleen cells and comparing the ability of these 
mixtures to stimulate PETLES when antigen was bound to one or the other type 
of spleen cell.  Thus, in this form of experiment, an identical MLR existed for 
both types of antigen presentation. As shown in Figs. 6 and 7, the same patterns 
of stimulation were observed,  namely syngeneic cells presented better than 
allogeneic cells (Fig.  6) or semisyngeneic cells (Fig.  7). Therefore, we conclude 
that MLR suppression cannot account for the genetic differences  observed in the 
ability of  antigen-pulsed spleen cells to activate PETLES from primed donors. 
An Mls Disparity between MHC Compatible Strains does not Inhibit Antigen 
Presentation.  The results presented in Figs. 6 and 7 demonstrate that a MLR 
induced by H-2-incompatible spleen cells does not suppress antigen presentation 
by spleen cells syngeneic to the responding PETLES population. The conclusion 
suggested by these results, that MLRs per se are not suppressive for antigen 
presentation, was supported by further experiments in which Mls-incompatible, 836  GENETICS  OF  T  CELL-MACROPHAGE  INTERACTIONS 
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FIG.  7.  Syngeneic spleen cells present antigen better than semisyngeneic spleen cells in 
the presence of the same MLR. 1 ×  10  5 DNPsOVA-primed B10 PETLES were cultured with 
mixtures of equal numbers of DNP~OVA-pulsed B10 spleen cells [B10(+)] and nonpulsed 
(B10  ×  B10.A)F1  spleen  cells  [FI(-)]  (O--©),  nonpulsed B10  spleen  cells  [B10(-)]  and 
DNPeOVA-pulsed F1 spleen cells [F~(+)] (Q--O),  or nonpulsed B10 spleen cells and non- 
pulsed F~  spleen cells  (A--A).  Stimulation was  assessed 5  days later by measuring the 
incorporation of a  16 h  pulse of tritiated methyl-thymidine. The results are expressed as 
cpm. 
MHC-identical  spleen  cells  were  used  to  present  antigen  (Table  II).  When 
BALB/c  PETLES  (H-2 d,  Mls b)  primed  to  DNPsOVA  were  stimulated  with 
DNPsOVA-pulsed DBA/2 spleen cells (H-2 d, Mlsa), the antigen-specific prolif- 
erative response achieved was almost as great as that obtained when syngeneic 
BALB/c spleen cells were used for antigen presentation, despite the large MLR. 
B10.D2 spleen cells (H-2 d, Mlsb),  which are identical  to BALB/c PETLES  at 
both  the H-2  and  Mls  loci  but  different at  many  other  loci,  also  presented 
DNPsOVA. In contrast,  B10 spleen cells (H-2 b, Mlsb), which are compatible at 
the Mls locus but incompatible at the MHC, did not present DNPeOVA effec- 
tively. Note that the magnitudes of the two types of MLR were similar (A cpm 
19,900 for the MHC incompatibility and A cpm 27,300 for the Mls incompatibil- 
ity), yet antigen  presentation occurred only in the case of MHC compatibility. 
These results and those of the previous section are interpreted as indicating that 
a MLR, in and of itself, does not suppress nor enhance the ability of spleen cells 
to present antigen to T lymphocytes. The failure of MHC allogeneic spleen cells 
to present antigen  well is, therefore,  interpreted as a  requirement for genetic 
identity  at  a  MHC  locus  in  order  for  effective interaction  between antigen- 
pulsed spleen cells and primed PETLES to occur. 
Genetic  Mapping  of  the  MHC  Genes  Required  for  Presentation  of 
DNPsOVA.  In order to  determine  at which  MHC loci common alleles  were 
necessary for effective interactions between primed T lymphocytes and antigen- AKIHIKO  YANO,  RONALD  H.  SCHWARTZ,  AND  WILLIAM  E.  PAUL 
TABLE II 
Mls Incompatibility does not Affect Antigen Presentation 
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A cpm 
Spleen  Mls  H-2  DNP6OVA  cpm _+  SEM  (DNPe-  A cpm 
Cells*  OVA)$  (MLR)§ 
BALB/c  b  d  Nonpulsed  1,300  _+  200 
Pulsed  47,000  _+  1,900  45,700 
DBA/2  a  d  Nonpulsed  28,600  _  400  27,300 
Pulsed  63,900  +_  4,400  35,300 
B10.D2  b  d  Nonpulsed  2,700  _  700  1,400 
Pulsed  59,500  +_  500  56,800 
B10  b  b  Nonpulsed  21,200  _+  1,800  19,900 
Pulsed  25,100  __  1,200  3,900 
* 1  ×  105  DNP6OVA-primed BALB/c PETLES were cultured with 1  ×  105  DNPeOVA-pulsed or 
nonpulsed BALB/c, DBA/2, B10.D2,  or B10 spleen cells for 5 days in microtiter plates. 
$ See footnote (*) to Table I. 
§ See footnote ($) to Table I. 
pulsed spleen cells to occur, the congenic resistant lines B10 and B10.A and their 
associated  recombinant  strains,  B10.A(4R)  (kkbbbbbbb) 2  and  B10.A(5R) 
(bbbkkdddd)  were  utilized  as  well  as  the  recombinant  strain  A.TL 
(skkkkkkkd). B10 and B10.A PETLES obtained from mice primed to DNP6OVA, 
were cultured with antigen-pulsed  or nonpulsed spleen cells from B10, B10.A, 
B10.A(4R), B10.A(SR), or A.TL mice. As shown in Table III, DNPeOVA-pulsed 
B10 spleen cells stimulated the  proliferation of B10 PETLES  (h cpm 20,100), 
while these same spleen cells were ineffective in stimulating B10.A PETLES (h 
cpm  1,000).  DNP6OVA-pulsed  B10.A  spleen  cells gave  opposite results;  they 
stimulated B10.A PETLES (h cpm 11,100) more effectively than B10 PETLES (A 
cpm 3,100).  The  B10.A(SR) recombinant  spleen cells behaved like  B10 spleen 
cells in that they stimulated B10 PETLES (A cpm 12,400)  more effectively than 
they stimulated B10.A PETLES (A cpm 1,600).  As summarized in Table V, this 
result suggests that genetic identity at the K  region or the I-A or I-B subregion 
is necessary to achieve effective interaction,  but that identity at the subregions 
of/to  the right of I-B, as well as at the G, S, and D  regions, is not sufficient. 
B10.A(4R) spleen cells (Table III) behaved like B10.A spleen cells in that they 
stimulated B10.A PETLES (h cpm 14,000) more effectively than they stimulated 
B10  PETLES  (h  cpm  3,300).  These  results  map  the  gene(s)  controlling  the 
interaction to the K  region or I-A subregion (Table V). In order to test whether 
identity at the K  region was necessary, A.TL spleen cells were used (Table III). 
These cells,  when pulsed with DNPsOVA,  stimulated  B10.A PETLES well (h 
cpm 10,400) but B10 PETLES poorly (A cpm 3,000).  Thus, compatibility at the K 
region is not essential for presentation of DNPeOVA. 
The above results, taken collectively, suggest that effective presentation can 
be achieved when compatibility at the I-A  subregion is present.  However, the 
2 Letters in parentheses refer to the haplotype source of  the K, I-A, I-B, l-J, I-E, I-C, S, G, and D 
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TABLE  III 
Responses of BlO and BIO.A PETLES to DNPeOVA-Pulsed Spleen Cells from Congenic 
Resistant Lines and Recombinant Strains 
PETLES 
Spleencells  B10  B10.A 
Nonpulsed  Pulsed  h cpm*  Nonpulsed  Pulsed  h cpm* 
B10  1,900 (500)$  22,000  (200)  20,100  10,200  (700)  11,200  (700)  1,000 
B10.A  10,500 (400)  13,600  (400)  3,100  1,200 (500)  12,300  (1,800)  11,100 
B10.A(5R)  6,300 (2,800)  18,700  (1,300)  12,400  21,100  (1,400)  22,700  (4,000)  1,600 
B10.A(4R)  13,400  (200)  16,700  (2,800)  3,300  1,900 (100)  15,900  (2,300)  14,000 
A.TL  8,800 (600)  11,800  (500)  3,000  13,100  (600)  23,500  (5,400)  10,400 
*  h cpm, cpm obtained  with DNP6OVA-pulsed spleen  cells  minus the cpm obtained  with nonpulsed 
spleen  cells. 
cpm; (1 SEM in  parentheses). 
TABLE  IV 
Responses of  A.TL and A .TH PETLES to DNP6O VA-Pulsed Spleen Cells from Congenic 
Resistant Lines and Recombinant Strains 
PETLES 
Spleencells  A.TL  A.TH 
Nonpulsed  Pulsed  A cpm*  Nonpulsed  Pulsed  A cpm* 
A.TL  1,600 (200)$  12,500  (1,400)  10,900  16,700 (1,600)  19,300  (1,800)  2,600 
A.TH  14,100 (700)  14,100  (1,500)  0  3,900 (1,000)  45,100  (600)  41,200 
SJL  14,900 (900)  17,400  (400)  2,500  12,200 (2,200)  55,800  (1,600)  43,600 
B10.A(4R)  10,900  (1,300)  25,100  (100)  14,200  16,200 (200)  20,800  (1,100)  4,600 
* cpm obtained with DNP6OVA-pulsed spleen cells minus the cpm obtained with nonpulsed  spleen cells. 
$ cpm; (1 SEM in parentheses). 
definitive proof of this hypothesis is presented in Table IV. A.TH (ssssssssd) and 
A.TL  (skkkkkkkd)  PETLES  were obtained  from  mice  primed  to  DNPeOVA. 
B10.A(4R) (kkbbbbbbb) spleen cells pulsed with DNP6OVA presented as well to 
A.TL PETLES (A cpm 14,200) as A.TL spleen cells (A cpm 11,000),  whereas SJL 
(sssssssss) spleen cells (A cpm 2,500)  and A.TH spleen cells (h cpm 0) were less 
effective. In contrast,  the same SJL and A.TH spleen cells presented well to 
A.TH PETLES (h cpm 43,600 for SJL and 41,200 for A.TH), demonstrating that 
they could function in antigen presentation.  In this case it was the B10.A(4R) 
and A.TL spleen cells which were ineffective in presenting DNP6OVA to A.TH 
PETLES. These results demonstrate that compatibility at only I-A [B10.A(4R) 
and A.TL] is sufficient for effective presentation of DNP6OVA, whereas compat- 
ibility at only K  (SJL and A.TL) is not (Table V). 
Discussion 
The  present  studies  have  demonstrated  the  capacity  of spleen  cells  from 
nonimmunized donors to bind and retain antigen in an immunogenic form and 
to effectively use this antigen to stimulate a proliferative response by primed T AKIHIKO  YANO,  RONALD  H.  SCHWARTZ,  AND  WILLIAM  E.  PAUL  839 
TABLE  V 
The I-A Subregion Controls the Interaction between DNP  eO  VA-Pulsed Spleen Cells and 
Primed T Lymphocytes 
BI0 PETLES  BI0.A PETLES 
Spleen Cells 
H-2 region identity* 
% of Syn- 
% Syngeneic  H-2 region identity*  geneic Re- 
Responses  sponseS 
B10  K,A,B,J,E,C,S,G,D  100  None  9 
B10.A  None  16  K,A,B,J,E,C,S,G,D  10_00 
B10.A(SR)  K,A ,B  62  J,E,C,S,G,D  14 
B10.A(4R)  None  16  K,A  127 
A.TL  None  15  A,B,J,E,D  94 
A.TL PETLES  A.TH PETLES 
A.TL  K ,A ,B ,J  ,E ,C  ,S  ,G  ,D  10___O0  K ,D  6 
A.TH  K ,D  0  K ,A ,B ,J  ,E ,C ,S  ,G  ,D  100 
SJL  K  23  K,A ,B,J,E,C,S,G  106 
B10.A(4R)  A  130  None  11 
* Letters refer to regions or subregions of the MHC which are shared by the stimulating spleen 
cells and the responding PETLES.  A,B,J,E, and C represent the subregions of/. 
S (A cpm of PETLES to DNPeOVA-pulsed allogeneic spleen cells/h cpm of the same PETLES to 
DNPeOVA-pulsed syngeneic spleen cells)  x  100. Underlined values indicate substantial 
responses. 
lymphocytes in vitro. The nature of the cell type within the spleen cell popula- 
tion which is responsible for antigen presentation is now under active study. 
Based on results from guinea pig systems, we anticipate that this cell will prove 
to be an adherent, Ia-bearing macrophage. 
In this paper we have demonstrated that there are certain genetic require- 
ments for effective antigen presentation. Spleen cells histoincompatible at the 
MHC did not present antigen as well as syngeneic spleen cells. F~ spleen cells 
were intermediate in presenting ability. Fine structure mapping indicated that 
identity of genes in the I-A  subregion of the MHC was sufficient for effective 
presentation of  the antigen, DNPeOVA. Identity at the K region only or at the I- 
B throughD regions was not sufficient. However, we were unable to rule out the 
formal possibility that some combination of K  and I.B  through G  genes might 
allow  effective antigen  presentation  since  the  appropriate  recombinants  for 
testing this possibility do not exist. Thus, we can not conclude that identity of 
the I-A  subregion is necessary, only that it is sufficient. 
The histocompatibility requirements did not appear to be the result of sup- 
pressive or enhancing effects generated by  MLRs  for the  following reasons. 
Mixtures of syngeneic and allogeneic or semisyngeneic spleen cells, in which all 
cultures developed the same MLR, still showed that syngeneic cells were supe- 
rior in antigen-presenting ability. In addition, the presence of a MLR generated 
by a  difference at the Mls  locus did not affect antigen presentation if the cells 
were histocompatible at the MHC. Thus, some other mechanism must account 
for the observations. 
At the present time, we favor the interpretation that primed T lymphocytes 
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living cells.  For cytotoxic cells nominally specific for viral (12), simple chemical 
(13), minor histocompatibility (14), or tumor-associated (15, 16) antigens, the 
association appears to be with K and D region gene products. For proliferating T 
cells in the guinea pig (1, 2) and delayed-typed hypersensitivity (DH) transfer- 
ring cells in the mouse (3), the association would appear to be principally with I 
region products. In our system, we postulate that the PETLES population from 
immunized donors contain T  cells which have been primed to  DNP6OVA  in 
association  with  syngeneic  I-A  region  gene  products.  Stimulation  with 
DNPsOVA on allogeneic spleen cells does not present the same combination of 
antigen and I-A subregion product and, therefore, would not be stimulatery. F1 
spleen cells do contain the correct allelic product and should be able to present 
DNPeOVA.  The fact that they did not present antigen as well as syngeneic 
spleen cells we attribute to a gene dose effect (they possess only one copy of the 
syngeneic allele) although this remains to be proven. 
This interpretation of the results leaves several unresolved questions. One is 
why the  allogeneic cells should present at all since they do not possess the 
correct MHC allelic products. We believe this is the result of a phenomenon we 
call "antigen carryover." By this we mean that antigen-pulsed allogeneic spleen 
cells transfer or release antigen after being placed in culture. This antigen is 
accepted or bound by residual syngeneic antigen-presenting cells which in turn 
stimulate primed T lymphocytes. Our reasons for thinking this phenomenon is 
occurring are threefold. One  is  that heat-killed cells do release stimulatory 
antigen albeit only to a small degree (Fig.  3).  Second, allogeneic stimulation 
occurs most often when the spleen cells are pulsed with high concentrations of 
antigen  (Fig.  4)  or  when  cell  interactions  are  maximized by  using  larger 
numbers of PETLES  in  round bottom plates  (R.  H.  Schwartz,  unpublished 
observations). Third, recent observations on antigen-specific T-cell populations 
which have been selected in vitro and are devoid of antigen-presenting cells, 
indicate that, under such conditions, allogeneic spleen cells do not present at all 
(A.  Yano,  unpublished observations).  On the other hand,  it is  possible that 
subpopulations of T lymphocytes exist which principally recognize free antigen; 
such cells might be triggered by antigen presented on allogeneic spleen cells. 
Indeed, Rosenwasser and Rosenthal (17) have recently studied the proliferative 
responses of lymph node T lymphocytes, depleted of syngeneic macrophages and 
reconstituted with  syngeneic or  allogeneic peritoneal exudate cells.  In  this 
system, no MHC  restriction was observed for stimulation by purified protein 
derivative of tuberculin or DNP-OVA. It is also possible,  based on the recent 
report of Gorczynski (18) that different subpopulations of antigen-presenting 
cells (macrophages) exist, some of which do and some of which do not show histo- 
compatibility restriction in antigen presentation. Finally, it is possible that I-A 
gene products which are serologically distinct may "cross-react" to some extent 
in their antigen-presentation function. 
The other unresolved problem is the failure of some workers to demonstrate 
histocompatibility requirements for helper T cell-macrophage interactions. Al- 
though the  very early studies  of Mitchison  (19) using  an  adoptive transfer 
system, suggested that bovine serum albumin bound to allogeneic macrophages 
was ineffective in eliciting antibody formation, the subsequent detailed studies 
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nin antibody-forming system indicated  that allogeneic  macrophages and even 
fibroblasts,  could  present antigen effectively.  This was despite  the fact  that  these 
same workers could demonstrate allogeneic  restrictions  in T-B cell  interactions 
(21,  22).  More recently,  however, Pierce  et al. (5),  Erb and Feldmann (4),  and 
Kappler and Marrack (23)  have been successful  in  demonstrating histocompati- 
bility  requirements for  helper  cell  induction  and antibody formation in  vitro  and 
in vivo.  Although this  recent work suggests that helper T cells  show the same 
histocompatibility  restrictions  in  their  interactions  with macrophages as do the 
proliferating  T cells  (1,  2)  and  the DH T cells  (3),  no  adequate explanation for  the 
lack of  agreement has yet been offered.  Even amongst those who agree that a 
histocompatibility restriction  exists in the interaction of macrophages  and 
helper T lymphocytes a consensus on the mechanism of the restrictions does not 
exist. Pierce et al. (5) have argued that the restriction occurs only in secondary 
antibody responses since allogeneic and syngeneic adherent cells work equally 
well in generating a primary plaque-forming cell (PFC) response to L-glutamic 
acid6°-L-alanine3°-L-tyrosine  ~°, whereas syngeneic  cells are markedly better than 
allogeneic cells in a secondary PFC response. The data of Cosenza and Leserman 
(24) on sheep erythrocyte  primary PFC responses as well as the primary prolifer- 
ation data of Thomas and Shevach (25, 26) support this concept. On the other 
hand, Erb and Feldmann (4) have isolated a macrophage factor which is neces- 
sary for primary helper cell induction in their system. This factor displays ge- 
netic restrictions despite the fact that it is generated by macrophages from un- 
primed donors. At the present time there is no obvious resolution of these con- 
flicting results. 
In conclusion, the results presented in this paper add to the growing body of 
evidence that suggests that most T cells recognize antigen in association with 
gene products of the MHC.  The mechanisms by which this might occur have 
been discussed adequately in other publications from this laboratory (27, 28) as 
well as from other laboratories (3, 29, 30). Suffice it to say that the uniqueness of 
T-cell recognition and responsiveness is felt to be epitomized by the requirement 
for histocompatible cell interactions. That this might be the basis for Ir gene 
control of the immune response is currently being investigated. 
Summary 
A method is described for stimulating proliferation in primed populations of 
murine T lymphocytes  using antigen bound to mitomycin-C-treated  spleen cells. 
This form of antigen presentation appears to be an active process because heat- 
killed spleen cells are ineffective, and because genetic similarity at the major 
histocompatibility complex (MHC) between the responder T cells and the pre- 
senting spleen cells is required for effective interactions. At all times examined, 
from day 3 to day 6 of  the proliferative response, syngeneic  spleen cells presented 
antigen better to  peritoneal exudate T-lymphocyte-enriched cells  (PETLES) 
than semisyngeneic F~ spleen cells, which in turn could present antigen better 
than totally allogeneic spleen cells.  Spleen cell mixing experiments demon- 
strated that these genetic restrictions were not the result of suppression by the 
ongoing mixed lymphocyte reactions  (MLR)  in the  allogeneic and  F~  cases. 
Furthermore, incompatibility at the Mls  locus generated a  strong MLR but 
failed to prevent antigen presentation if the spleen cells and PETLES were H-2 842  GENETICS  OF  T  CELL-MACROPHAGE  INTERACTIONS 
compatible.  Genetic mapping studies demonstrated that compatibility at only 
the I-A  subregion of the  MHC  was  sufficient for effective presentation of the 
antigen,  dinitrophenylated ovalbumin.  Compatibility at only the K  region, or 
the K  and D  regions was not sufficient. These results support the concept that 
functional activation of primed, proliferating T lymphocytes requires the partic- 
ipation of gene products coded for by the I  region of the MHC. This conclusion is 
consistent with  a  growing  body of evidence which  suggests  that most T  cells 
recognize antigen in association with MHC gene products. 
Received for publication 23 May 1977. 
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